Risingsun Health to stop selling skin treatments for cancer FDA says don't work

FDA logo: consumer ally - risingsun health to stop selling unapproved drugs
FDA logo: consumer ally - risingsun health to stop selling unapproved drugs

The Food and Drug Administration announced Wednesday that a Montana drug company agreed to stop selling what it calls unproven treatments for breast cancer and other serious illnesses.

Toby McAdam and Greta Armstrong, doing business as Risingsun Health and The Center for Complimentary and Alternative Health of Livingston, Mont., signed a consent decree prohibiting them from manufacturing and selling unapproved new drugs and adulterated or misbranded dietary supplements in violation of the law.

"The FDA will not tolerate unsubstantiated health or disease claims that may mislead customers," said Deborah M. Autor, director of the Office of Compliance in FDA's Center for Drug Evaluation and Research, in a statement. "The FDA is committed to ensuring that consumers do not become victims of false cures."